Pancreatic lesions may occur more frequently than previously thought

by American Association for Cancer ResearchThe Pancreas. Credit: Illustration from Anatomy & Physiology Connexions Web sitehttp://cnx.org/content/col11496/1.6//Wikimedia Commons,C

Updated on: February 20,2024 20

Pancreatic lesions may occur more frequently than previously thought

by American Association for Cancer ResearchThe Pancreas. Credit: Illustration from Anatomy & Physiology Connexions Web sitehttp://cnx.org/content/col11496/1.6//Wikimedia Commons,C

Updated on:February 20,2024 20

Researchers find less risky way to monitor breast cancer progression

by CU Anschutz Medical CampusSchematic for identifying subset of binding sites with TF footprints. (A) When TFs or nucleosomes are bound at TFBSs, they protect different lengths of DNA from nucle

Updated on: February 20,2024 11

Researchers find less risky way to monitor breast cancer progression

by CU Anschutz Medical CampusSchematic for identifying subset of binding sites with TF footprints. (A) When TFs or nucleosomes are bound at TFBSs, they protect different lengths of DNA from nucle

Updated on:February 20,2024 11

Drug that targets scar-like tissue in tumors shows promise for aggressive pancreatic cancer

by Garvan Institute of Medical ResearchThe new drug, PXS-5505, breaking down the fibrotic tissue around pancreatic cancer cells. Credit: Ella MaruFindings from the Garvan Institute of Medical Res

Updated on: February 20,2024 10

Drug that targets scar-like tissue in tumors shows promise for aggressive pancreatic cancer

by Garvan Institute of Medical ResearchThe new drug, PXS-5505, breaking down the fibrotic tissue around pancreatic cancer cells. Credit: Ella MaruFindings from the Garvan Institute of Medical Res

Updated on:February 20,2024 10

Researchers turn cancer cells into less harmful cell types

by University of BaselHigh-throughput drug screen reveals estrogen receptor α (ERα) induction in triple-negative breast cancer (TNBC) upon polo-like kinase 1 (PLK1) inhibition. A Schematic of the

Updated on: February 20,2024 16

Researchers turn cancer cells into less harmful cell types

by University of BaselHigh-throughput drug screen reveals estrogen receptor α (ERα) induction in triple-negative breast cancer (TNBC) upon polo-like kinase 1 (PLK1) inhibition. A Schematic of the

Updated on:February 20,2024 16

Study validates diagnostic assay for Asian cancers

by National University of SingaporeGraphical overview of workflow and coverage of cancer subtypes in the Asian Pan-Cancer Panel. A total of six workdays are required from sample QC to reliable ge

Updated on: February 20,2024 12

Study validates diagnostic assay for Asian cancers

by National University of SingaporeGraphical overview of workflow and coverage of cancer subtypes in the Asian Pan-Cancer Panel. A total of six workdays are required from sample QC to reliable ge

Updated on:February 20,2024 12

Toward a personalized approach to the study and treatment of bone cancers

by Lund UniversityPrimary acute myeloid leukemia cells preferentially home and engraft in MSOD-B hOss.a, Experimental scheme of AML patient sample transplantation. b, Representative histological

Updated on: February 20,2024 17

Toward a personalized approach to the study and treatment of bone cancers

by Lund UniversityPrimary acute myeloid leukemia cells preferentially home and engraft in MSOD-B hOss.a, Experimental scheme of AML patient sample transplantation. b, Representative histological

Updated on:February 20,2024 17

Liquid biopsy predicts early disease progression, potential survival in patients with advanced breast cancer

by Johns Hopkins UniversityCredit: Unsplash/CC0 Public DomainA novel, automated liquid biopsy test in development by researchers at the Johns Hopkins Kimmel Cancer Center can be used to predict e

Updated on: February 20,2024 16

Liquid biopsy predicts early disease progression, potential survival in patients with advanced breast cancer

by Johns Hopkins UniversityCredit: Unsplash/CC0 Public DomainA novel, automated liquid biopsy test in development by researchers at the Johns Hopkins Kimmel Cancer Center can be used to predict e

Updated on:February 20,2024 16

A comprehensive proteogenomic dataset to help cancer researchers unravel molecular mysteries

by National Institutes of HealthTumor types and data types of the CPTAC pan-cancer dataset. Overview of the available molecular data types for the CPTAC pan-cancer cohort (n= 1072, see Tabl

Updated on: February 20,2024 12

A comprehensive proteogenomic dataset to help cancer researchers unravel molecular mysteries

by National Institutes of HealthTumor types and data types of the CPTAC pan-cancer dataset. Overview of the available molecular data types for the CPTAC pan-cancer cohort (n= 1072, see Tabl

Updated on:February 20,2024 12

Researchers discover a new approach to boost the immune system

by Aarhus UniversityCancer cells. Credit: Dr. Cecil Fox, National Cancer InstituteImmunotherapy is a type of cancer treatment that uses the body's own immune system to fight tumor cells. Whil

Updated on: February 20,2024 20

Researchers discover a new approach to boost the immune system

by Aarhus UniversityCancer cells. Credit: Dr. Cecil Fox, National Cancer InstituteImmunotherapy is a type of cancer treatment that uses the body's own immune system to fight tumor cells. Whil

Updated on:February 20,2024 20

Researchers develop 'Goldilocks drug' to treat triple-negative breast cancer

by Mikayla Mace Kelley,University of ArizonacSNX1.3 competitively inhibits binding of EGFR to SNX1.ARibbon drawing of EGFR kinase domain (PDB ID 5CNO) and SNX1 Bar domain (PDB ID 4FZ

Updated on: February 20,2024 11

Researchers develop 'Goldilocks drug' to treat triple-negative breast cancer

by Mikayla Mace Kelley,University of ArizonacSNX1.3 competitively inhibits binding of EGFR to SNX1.ARibbon drawing of EGFR kinase domain (PDB ID 5CNO) and SNX1 Bar domain (PDB ID 4FZ

Updated on:February 20,2024 11

Researchers make major advance with cancer-killing antibody-drug conjugates

by Doug Bennett,University of FloridaCredit:Journal of Medicinal Chemistry(2023). DOI: 10.1021/acs.jmedchem.2c01771Building a new precision cancer treatment comes with no shortage of

Updated on: February 20,2024 18

Researchers make major advance with cancer-killing antibody-drug conjugates

by Doug Bennett,University of FloridaCredit:Journal of Medicinal Chemistry(2023). DOI: 10.1021/acs.jmedchem.2c01771Building a new precision cancer treatment comes with no shortage of

Updated on:February 20,2024 18

Cancer-targeting virus therapy combined with radiation more effective against brain cancer than either one alone

by Gillian Rutherford,University of AlbertaResearchers Mary Hitt (left) and Quinn Storozynsky found that using a cancer-targeting virus therapy at the same time as radiation gives more benefit t

Updated on: February 19,2024 14

Cancer-targeting virus therapy combined with radiation more effective against brain cancer than either one alone

by Gillian Rutherford,University of AlbertaResearchers Mary Hitt (left) and Quinn Storozynsky found that using a cancer-targeting virus therapy at the same time as radiation gives more benefit t

Updated on:February 19,2024 14